PROGLYCEM
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for PROGLYCEM, covering 2008-12-17 to 2024-07-18. Get the full timeline:
Most recent: FDA Approved: PROGLYCEM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)